Biotech giant Amgen is doubling down on a Durham health data startup with ties to Duke

January 15, 2021

Amgen, one of the largest biotechnology companies in the world, is doubling down on its investment into a Durham health data startup called NoviSci. NoviSci, founded by two Duke University professors, builds statistical software that companies use to evaluate the effectiveness of drugs in patients.

Categories: NoviSci

Genentech Launches $1B+ RNA Collaboration with Ribometrix

January 6, 2021

Genentech, a member of the Roche Group, will apply Ribometrix’s discovery platform to discover, develop, and commercialize small molecule drug candidates against RNA targets, through a collaboration that could generate more than $1 billion for the Durham, NC-based developer of RNA-based small molecule therapeutics.

Categories: Ribometrix

410 Medical Awarded FDA 510k Clearance for LifeFlow PLUS

November 3, 2020

Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS).

Categories: 410 Medical

National Academy of Engineering Recognizes Ligler With Leadership Award

October 5, 2020

Frances S. Ligler, Ross Lampe Distinguished Professor in the UNC/NC State Joint Department of Biomedical Engineering, has been recognized by the National Academy of Engineering (NAE) with its Simon Ramo Founders Award.

Categories: Advisory Board News

BME Spin-out Company Altis Biosystems announces completion of a $3.1 million investment

September 23, 2020

Altis Biosystems, a company co-founded by BME Associate Professor Scott Magness and former chair Dr. Nancy Allbritton, recently announced completion of a $3.1 million seed investment led by VentureSouth.

Categories: Altis Biosystems